Todd M. Przybycien began his career at Monsanto Agricultural Co. before joining the chemical engineering faculty of Rensselaer Polytechnic Institute (RPI) in 1991 and launching a teaching and research program in biomanufacturing. He then spent 20 years on the faculty of Carnegie Mellon Univ. (CMU), also becoming founding head of the Biomedical Engineering Dept. He returned to RPI in 2018. He has collaborated with a range of large and small biotech companies with support from CESMII, FDA, the Gates Foundation, NIIMBL and NSF. Within AIChE, he chaired the Food, Pharmaceutical and Bioengineering Div. and served as the Area 15c (Bioengineering) program chair. He has served on the managing board of AIChE’s Society for Biological Engineering since 2010, and on CEP’s editorial board since 2014. He is a Life Member and Fellow of AIChE.